Detail Information of Microbiota Influence

General Information of Drug Transporter (DT)
DT ID DTD0019 Transporter Info
Gene Name SLC10A1
Transporter Name Sodium/taurocholate cotransporting polypeptide
Gene ID
6554
UniProt ID
Q14973
Microbiota Influence of This DT (MBI)

Bacteria: Verrucomicrobiota

   Genus: Akkermansia

     Akkermansia muciniphila 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Up regulating of SLC10A1 expression in metabolic dysfunction-associated fatty liver disease condition [1]

Studied Phenotype

 Metabolic dysfunction-associated fatty liver disease [ICD11: DB95]

Studied Tissue

 Liver

In Vivo Model

 C57BL/6 mice

Detailed Description

 The Akkermansia muciniphila ATCC BAA-835 has been reported to increase the expression of the drug transporter SLC10A1.

Bacteria: Host unspecified microbiota

   Genus: Unknown microbiota

     Host unspecified microbiota 

Click to Show/Hide the Full List 4 Microbe Influence Related to This Species      

       Microbe Influence 1

 Down regulating of SLC10A1 expression in the health condition [2] , [3]

Regulating Factor
Trimethylamine oxide

Studied Tissue

 Liver

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite trimethylamine oxide generated from the metabolism of l-carnitine by the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC10A1.

       Microbe Influence 2

 Up regulating of SLC10A1 expression in the health condition [4] , [5]

Regulating Factor
Lithocholic acid

Regulation Mechanism

 via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) Transcription Factor Info

Studied Tissue

 Liver

In Vivo Model

 IQI mice

Detailed Description

 The metabolite lithocholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLC10A1.

       Microbe Influence 3

 Down regulating of SLC10A1 expression in the health condition [6] , [7]

Regulating Factor
Bile acid (Deoxycholic acid)

Studied Tissue

 Liver

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (deoxycholic acid) generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC10A1.

       Microbe Influence 4

 Down regulating of SLC10A1 expression in conventional mice compared with germ-free mice [8]

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Liver

In Vivo Model

 C57BL/6J mice

Detailed Description

 The host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC10A1.
References
1 Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis. Gut Microbes. 2021 Jan-Dec;13(1):1-19.
2 Gut Microbiome and Response to Cardiovascular Drugs. Circ Genom Precis Med. 2019 Sep;12(9):421-429.
3 Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013 May;19(5):576-85.
4 Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids. Drug Metab Dispos. 2015 Oct;43(10):1505-21.
5 Intestinal flora induces the expression of Cyp3a in the mouse liver. Xenobiotica. 2009 Apr;39(4):323-34.
6 Bile Acids Activated Receptors Regulate Innate Immunity. Front Immunol. 2018 Aug 13;9:1853.
7 Importance of Large Intestine in Regulating Bile Acids and Glucagon-Like Peptide-1 in Germ-Free Mice. Drug Metab Dispos. 2015 Oct;43(10):1544-56.
8 Developmental Regulation of Drug-Processing Genes in Livers of Germ-Free Mice. Toxicol Sci. 2015 Sep;147(1):84-103.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.